Your Solutions
Pharmaprojects
The industry standard for tracking and analyzing the global drug R&D landscape
Product Login 
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution
Product Login 
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence
Product Login 
Medtech Insight
The latest high-value news, analysis and strategic insights on the global medical technology sector
Product Login 
TrialScope Intelligence
Critical Insight for Global Clinical Trial Disclosure Compliance
*Limited License
Product Login *Limited License
Evaluate Pharma
The Definitive Source of Consensus Forecasts & ML-driven Commercial Analysis
*Limited License
Product Login *Limited License
BioSci DB
Comprehensive Peer-reviewed Reference Database on Biopharma Alliances
*Limited License
Product Login *Limited License
Meet the team
Alex Gannett (Global)
Global Account Director, Strategic Solutions
Citeline
Daniel Hoopes
Global Account Director, Account Management
Citeline
Jennifer Corona (Global)
Client Success Manager
Citeline
Andy Mills (Global)
Principal, Customer Success
Evaluate/Citeline
Robert Wu (APAC)
Client Success Manager
Citeline
Training & Help
We have a library of prerecorded training. For more information, reach out to the client services team. You can view our video tutorial library.
View our library:
For access issues and technical questions, please contact us at the client services email address below, and we will get back to you promptly.
[email protected] / US Toll-Free +1 888 670 8900 / US Toll +1 332 266 9501 / UK & Europe +44 203 480 7600
Ask the analyst
Your status as a loyalty partner includes unlimited access to our highly acclaimed Ask-the-Analyst™ service. Tap into the expertise of our global team of analysts, who can provide you with the answers you need to help fully inform your business decisions. With a 24-hour response time, Ask-the-Analyst offers you authoritative information to help you make faster, smarter decisions.
Our Ask-the-Analyst team of industry experts leverages the complete suite of Citeline products to bring you the answers you’re looking for. Our professional team is poised to deliver you meaningful insights you can immediately act upon and all questions received are strictly confidential.
Latest Monthly Newsletter
Edition: December 2025
EDITORIAL CONTENTS (incl. Podcasts, Webinars)
- Notable Podcast: Drug Fix: Understanding the US FDA’s CDER Leadership Shuffle
- Notable Webinar: 2026 Preview Webinar (Jan 22, 2026)
- Notable Webinar: Inside #JPM2026: The Stories Behind the Summit (Feb 5, 2026)
DEALS & FINANCING (incl. M&As, Licensing, Financing)
- Notable M&A: BioMarin to Acquire Amicus Therapeutics for $4.8B
- Notable M&A: Sanofi to Acquire Dynavax for $2.2B
- Notable Licensing: Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73 totalling $2B
- Notable Licensing: Pfizer Enters into Exclusive Collaboration and License Agreement with Fosun Pharma’s YaoPharma for GLP-1R Agonist YP05002 totalling $2.1B
- Notable Financing: Braveheart Bio Launches with $185M Series A Round
- Notable Financing: Medline Nets $6.1B in Upsized IPO
KEY R&D EVENTS (incl. Top-line Readouts, Analyst Commentary, Approval/CRL)
- Notable Analysis: BeOne Medicines | BGB-16673 | CLL (Phase 3): “BeOne's BGB-16673 matches bexobrutideg on response rates in heavily pre-treated CLL but loses out on safety profile…”
- Notable Analysis: Galapagos | GLPG5101 | Mantle Cell Lymphoma (Phase 2): “GLPG5101 continues to impress in mantle cell lymphoma despite the windup of Galapagos' cell therapy unit…”
- Notable Analysis: Ultragenyx | BPS804 | Osteogenesis Imperfecta (Phase 3): “Setrusumab Fails in Pivotal Trials for Osteogenesis Imperfecta, Casting Doubt on Future Development…”
- Notable Analysis: uniQure | AMT-130 | Huntington's Disease (Phase 2): “FDA deems AMT-130 BLA data insufficient, leaving path forward in Huntington's disease unclear…”
RESEARCH REPORTS (incl. Forecast, Thought Leadership, KOL Interview)
- Notable Report: 2025 Post-ASH Report
- Notable Report: In Vivo Outlook 2026
- Notable Report: 2026 Investor & Medical Conference Calendar
- Notable Report: Epi & Market Forecast: Amyotrophic Lateral Sclerosis (ALS)
- Notable Report: Epi & Market Forecast: Autism Spectrum Disorders
- Notable Report: Epi & Market Forecast: Cervical Cancer
- Notable Report: Epi & Market Forecast: Glioblastoma
- Notable Report: KOL Interview: Schizophrenia | ALS | Spinal Muscular Atrophy | Systemic Lupus Erythematosus
Latest Editorial Podcasts
Conference Disclosures via Trialtrove
Last Updated: December 2025
Every year, Trialtrove analysts review thousands of abstracts from 160+ scientific meetings/conferences and update the corresponding trial records when the information is in scope. This includes, but not limited to: trial results, trial design, study status, patient accrual information. Below, we have provided search links that will take you directly to trials where information was added from a selection of major meetings that have taken place since 2021.
Note: Require research support on scientific meetings not under below list? Submit your inquiry via Ask the Analyst!
| Therapeutic Area | Conference | 2021 | 2022 | 2023 | 2024 | 2025 |
| Autoimmune/ Inflammation |
American Academy of Dermatology (AAD) | LINK | LINK | LINK | LINK | LINK |
| Digestive Disease Week (DDW) | LINK | LINK | LINK | LINK |
LINK | |
| American Thoracic Society (ATS) | LINK | LINK | LINK | LINK | LINK | |
| European Congress of Rheumatology (EULAR) | LINK | LINK | LINK | LINK |
LINK | |
| American College of Rheumatology (ACR Convergence) | LINK | LINK | LINK | LINK | LINK | |
| Cardiovascular | American College of Cardiology (ACC) | LINK | LINK | LINK | LINK |
LINK |
| European Society of Hypertension & International Society of Hypertension (ESH-ISH) | LINK | LINK | LINK | LINK | LINK | |
| International Society on Thrombosis and Hemostasis (ISTH) | LINK | LINK | LINK | LINK |
LINK | |
| CNS | American Academy of Neurology (AAN) | LINK | LINK | LINK | LINK | LINK |
| European Academy of Neurology (EAN) | LINK | LINK | LINK | LINK |
LINK | |
| Alzheimer's Association International Conference (AAIC) | LINK | LINK | LINK | LINK |
LINK | |
| European Committee for Treatment & Research in Multiple Sclerosis (ECTRIMS) | LINK | LINK | LINK | LINK | LINK | |
| World Congress of Neurology (WCN) | LINK | - | LINK | - | LINK | |
| Infectious Disease |
Asian Pacific Association for the Study of the Liver (APASL) | LINK | LINK | LINK | LINK | LINK |
| Conference on Retroviruses and Opportunistic Infections (CROI) | LINK | LINK | LINK | LINK | LINK | |
| European Association for the Study of Liver (EASL) | LINK | LINK | LINK | LINK | LINK | |
| American Association for the Study of Liver Diseases (AASLD) | LINK | LINK | LINK | LINK | LINK | |
| Metabolic/ Endocrinology |
American Diabetes Association (ADA) | LINK | LINK | LINK | LINK | LINK |
| European Association for the Study of Liver (EASL) | LINK | LINK | LINK | LINK | LINK |
|
| European Association for the Study of Diabetes (EASD) | LINK | LINK | LINK | LINK | LINK | |
| American Association for the Study of Liver Diseases (AASLD) | LINK | LINK | LINK | LINK | LINK | |
| Oncology | American Association of Cancer Research (AACR) | LINK | LINK | LINK | LINK | LINK |
| American Society of Clinical Oncology (ASCO) | LINK | LINK | LINK | LINK | LINK | |
| European Society of Medical Oncology (ESMO) | LINK | LINK | LINK | LINK | LINK | |
| American Society of Hematology (ASH) | LINK | LINK | LINK | LINK |
LINK | |
| Ophthalmology | Asia-Pacific Academy of Ophthalmology (APAO) | LINK | - | LINK | - | LINK |
| Association for Research in Vision and Ophthalmology (ARVO) | LINK | LINK | LINK | LINK | LINK | |
| European Society of Ophthalmology (SOE) | N/A | - | LINK | - | LINK | |
| World Glaucoma Congress (WGC) | LINK | - | LINK | - | LINK |
Note:
Blank field - future meeting/not yet covered
Dash (-) - no meeting/biannual schedule
N/A - abstracts not publicly available